Clinical Trial Update: A Single Dose, Phase 1 Study of YH35324 in Patients with Various Allergic Diseases [Phase 1]

View source ↗

Summary

A single-dose, Phase 1 study of YH35324 in patients with allergic diseases, including chronic spontaneous urticaria and chronic inducible urticarias, has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cold Urticaria
• Inducible Urticaria
• Spontaneous Urticaria

Drugs mentioned

• YH35324

Snippet

Sponsor: Yuhan Corporation | Conditions: Allergic Disease, Chronic Spontaneous Urticaria | Phase 1 | Status: COMPLETED